Amgen, Inc. AMGN shares are trading higher on Thursday, after the company and Adaptive announced they will partner to develop a coronavirus therapeutic.
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Amgen's shares were trading up 5.4% to $208.49 at time of publication. The stock has a 52-week high of $244.99 and a 52-week low of $166.30.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
